TREA

79171662 - PLEXUS

Follow

Information

  • Trademark
  • 79171662
  • Serial Number
    79171662
  • Registration Number
    5024473
  • Filing Date
    December 22, 2014
    10 years ago
  • Registration Date
    August 23, 2016
    8 years ago
  • Transaction Date
    October 25, 2024
    9 months ago
  • Status Date
    July 11, 2022
    3 years ago
  • Published for Opposition Date
    June 07, 2016
    9 years ago
  • Location Date
    July 11, 2022
    3 years ago
  • Status Code
    739
  • Current Location
    GENERIC WEB UPDATE
    Employee Name
    BOULTON, KELLY
  • Attorney Docket Number
    38963/567468
    Attorney Name
    Michele M. Glessner
    Law Office Assigned Location Code
    L20
  • Owners
Information
Mark Drawing Code
4
Mark Identification
PLEXUS
Case File Statements
  • GS0101: Surgical apparatus and instruments for use in endovascular procedures and for treating cardiovascular disease, namely, thoracic stents; synthetic thoracic stent grafts; synthetic stent grafts; synthetic stent graft systems comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems comprising more than one component comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems and devices comprising components of more than one type of stent graft comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; thoracic synthetic stent graft systems comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; thoracic stent graft devices; prosthetic systemic vascular grafts; prosthetic vascular straight grafts; prosthetic vascular abdominal grafts; prosthetic vascular thoracic grafts; prosthetic vascular branched grafts; prosthetic vascular pre-curved grafts; prosthetic vascular aortic arch grafts; prosthetic vascular branched arch grafts; delivery systems for synthetic stent graft systems comprised of medical instruments for intraluminal emplacement of stents or of synthetic stent grafts, namely, stent or synthetic stent graft delivery systems; aneurysm repair systems comprised of catheter delivered stent grafts, medical instruments for intraluminal emplacement of stents or stent systems or of synthetic stent grafts, namely, stent delivery systems or stent graft delivery systems or synthetic stent graft delivery systems; cardiac valves for surgical prostheses; cardiac valve replacement systems, namely, prosthetic cardiac valves; heart valves, namely, prosthetic heart valves; heart valve conduits, namely, catheters for implanting heart valves; cardiac patches, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; vascular patches, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, namely, surgical mesh comprised primarily of prosthetic materials; medical apparatus and instruments for use in endovascular procedures and for treating cardiovascular disease; grafts, namely, prosthetic vascular grafts, prosthetic endovascular grafts, stents, and vascular prostheses; prosthetic vascular woven grafts; surgical implants comprising prosthetic materials; stents, patches, namely, patches for repair and reconstruction of internal tissue, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; prostheses, namely, artificial surgical prostheses; surgical implants comprising artificial material; suture materials; patches for repair and reconstruction of internal tissue, namely, surgical mesh comprised primarily of prosthetic materials; implantable medical devices, namely, implants consisting of prosthetic materials, synthetic vascular prostheses, prosthetic vascular grafts, synthetic heart valve conduits, cardiac valves for surgical prostheses, stents, prosthetic vascular grafts, vascular prostheses, prosthetic vascular grafts, prosthetic endovascular grafts, and catheters; artificial vascular grafts; artificial endovascular grafts; surgical graft materials, namely, prosthetic vascular grafts, vascular prostheses for the treatment of aneurysmal or occlusive arterial disease medical devices for use in endovascular procedures for treating cardiovascular disease; stents; thoracic stents; artificial thoracic stent grafts; thoracic stent graft systems comprising synthetic stent grafts and stent delivery systems; delivery systems for stent graft systems comprising stent delivery systems; aneurysm repair systems comprised of catheter delivered artificial stent grafts and stent delivery systems; cardiac valves for surgical prostheses; cardiac valve replacement systems comprised of artificial cardiac valves; artificial heart valves; heart valve conduits namely, catheters for implanting heart valves; cardiac patches and vascular patches, namely, surgical mesh comprised primarily of prosthetic materials; parts and fittings for all of the aforementioned goods
Case File Event Statements
  • 9/3/2015 - 9 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 10/2/2015 - 9 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 9/4/2015 - 9 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/4/2015 - 9 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/8/2015 - 9 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 9/11/2015 - 9 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/12/2015 - 9 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 9/15/2015 - 9 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 9/15/2015 - 9 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 4/28/2016 - 9 years ago
    19 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 3/15/2016 - 9 years ago
    11 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 3/15/2016 - 9 years ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/29/2016 - 9 years ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/15/2016 - 9 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/29/2016 - 9 years ago
    12 - ASSIGNED TO LIE Type: ALIE
  • 3/29/2016 - 9 years ago
    15 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 4/28/2016 - 9 years ago
    17 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 4/28/2016 - 9 years ago
    18 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 4/28/2016 - 9 years ago
    16 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/28/2016 - 9 years ago
    20 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/30/2016 - 9 years ago
    22 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 5/18/2016 - 9 years ago
    23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/28/2016 - 9 years ago
    28 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 8/23/2016 - 8 years ago
    29 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/29/2016 - 9 years ago
    21 - ASSIGNED TO LIE Type: ALIE
  • 6/1/2016 - 9 years ago
    24 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 6/1/2016 - 9 years ago
    25 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 6/7/2016 - 9 years ago
    26 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/7/2016 - 9 years ago
    27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/19/2017 - 8 years ago
    32 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 12/21/2021 - 3 years ago
    35 - TEAS SECTION 71 & 15 RECEIVED Type: ES75
  • 11/23/2016 - 8 years ago
    30 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 1/19/2017 - 8 years ago
    31 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 2/17/2017 - 8 years ago
    33 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 8/23/2021 - 3 years ago
    34 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3
  • 7/11/2022 - 3 years ago
    37 - REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. Type: C75A
  • 7/11/2022 - 3 years ago
    38 - NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED Type: NA75
  • 6/6/2022 - 3 years ago
    36 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 10/24/2024 - 9 months ago
    39 - INTERNATIONAL REGISTRATION RENEWED Type: RNWL